Filing Flows › Zymeworks (ZYME) › Recalls, complaints & regulation
Zymeworks (ZYME): clinical trials
Zymeworks (ZYME) beyond its filings: 2 active clinical trials.
Zymeworks' latest quarter
Zymeworks, Q2 2026: revenue $4.6M (-91% year over year), operating margin -919.0%, net loss $45.0M, operating cash flow −$31.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Zymeworks have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.